Nordson AI Stock Analysis
Want to see NDSN full AI Analyst Report?
Nordson (NDSN) AI Stock Analysis
Nordson
(NASDAQ:NDSN)
NDSN scores well on financial quality and earnings outlook: strong free-cash-flow generation, resilient margins, improving leverage, and a guidance raise supported by record results and a sharply higher backlog. The score is held back by a premium valuation (P/E ~33) and only mixed near-term technical momentum, with some risk from reliance on cyclical ATS strength and still-meaningful absolute debt.
Nordson Key Performance Indicators (KPIs)
Sales by SegmentBreaks down revenue generated by each business segment, indicating which areas are driving growth and which may need strategic adjustments.
Nordson’s revenue mix reflects deliberate portfolio reshaping: legacy Industrial Coating was exited and Advanced Technology reset from its pre‑2022 scale but has since regained momentum on semiconductor/electronics demand, while Industrial Precision and Medical & Fluid are delivering broad‑based order and backlog strength that underpins the company’s raised guidance. Strong cashflow and lower leverage support disciplined bolt‑on M&A, but near‑term margin upside is constrained by inflationary input pressure and a regulatory-driven medical product change.
Nordson (NDSN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $17.97B
- Dividend Yield
- 1.05%
- Average Volume (3M)
- 378.02K
- Price to Earnings (P/E)
- 32.5
- Beta (1Y)
- 1.01
- Revenue Growth
- 7.02%
- EPS Growth
- 24.24%
- Country
- US
- Employees
- 8,200
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Machinery
Nordson Business Overview & Revenue Model
Company Description
Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment prov...
How the Company Makes Money
Nordson primarily makes money by selling engineered industrial equipment and the recurring products and services that keep that equipment running in customers’ production environments. Key revenue streams include: 1) Capital equipment sales: Nordson...
Nordson Earnings Call Summary
The call was broadly positive: the company reported record sales, record EBITDA and adjusted EPS, strong free cash flow and a materially increased backlog, and it raised full-year guidance. Segment performance was strong across the board with exceptional outperformance in Advanced Technology Solutions and solid showings in Medical & Fluid Solutions. Headwinds include a noncash mark-to-market charge, ongoing inflationary pressures, a divestiture that reduced comparable medical sales, and concentration of upside in a cyclical segment (ATS) that may face tougher comparables next year. Overall financial strength (cash generation, deleveraging, margins) and constructive guidance outweighed the limited headwinds.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Nordson raised its fiscal 2026 full‑year guidance to $3.035–$3.075 billion in sales and $11.80–$12.00 in adjusted diluted EPS (assuming current FX rates, i.e., neutral FX), citing 35% year‑over‑year backlog growth and sustained order‑entry momentum; the update follows a record Q3 (sales $818 million, +10% YoY; organic +12%), record Q3 adjusted EPS of $3.25 (a $0.10 beat, +19% YoY), record EBITDA of $262 million (32% of sales) and adjusted operating profit of $226 million (28% of sales), with strong cash generation (Q3 free cash flow $237 million; ~144% conversion of net income), cash on hand $113 million, net debt ~$1.6 billion and leverage of 1.7x, and an expected full‑year tax rate near 18%; management cited these metrics, plus YTD capex of $40 million and year‑to‑date shareholder returns ($137 million dividends, $159 million repurchases), as the basis for the upgraded outlook.
Nordson Financial Statement Overview
Summary
Strong overall fundamentals driven by excellent cash generation (TTM FCF ~$724M, ~94% of net income) and resilient profitability (gross margin ~54–56%, net margin ~18.6% TTM). Balance sheet trends are improving with deleveraging (D/E ~0.53 TTM; leverage noted at ~1.7x), though absolute debt remains sizable (~$1.6–$1.7B) and TTM operating margin is below prior annual levels, indicating some mix/cost pressure.
Income Statement
84Very PositiveBalance Sheet
72PositiveCash Flow
87Very Positive| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.98B | 2.79B | 2.69B | 2.63B | 2.59B | 2.36B |
| Gross Profit | 1.65B | 1.54B | 1.49B | 1.43B | 1.43B | 1.32B |
| EBITDA | 947.41M | 849.28M | 810.58M | 786.74M | 771.62M | 703.55M |
| Net Income | 555.18M | 484.47M | 467.28M | 487.49M | 513.10M | 454.37M |
Balance Sheet | ||||||
| Total Assets | 5.95B | 5.92B | 6.00B | 5.25B | 3.82B | 3.79B |
| Cash, Cash Equivalents and Short-Term Investments | 113.43M | 108.44M | 115.95M | 115.68M | 163.46M | 299.97M |
| Total Debt | 1.81B | 2.16B | 2.40B | 1.96B | 951.22M | 1.05B |
| Total Liabilities | 2.68B | 2.87B | 3.07B | 2.65B | 1.53B | 1.63B |
| Stockholders Equity | 3.27B | 3.04B | 2.93B | 2.60B | 2.29B | 2.16B |
Cash Flow | ||||||
| Free Cash Flow | 728.49M | 661.12M | 491.78M | 606.70M | 461.70M | 507.62M |
| Operating Cash Flow | 777.86M | 719.17M | 556.19M | 641.28M | 513.13M | 545.93M |
| Investing Cash Flow | -37.08M | -26.69M | -844.40M | -1.44B | -222.76M | -33.17M |
| Financing Cash Flow | -762.18M | -706.43M | 294.50M | 750.51M | -416.01M | -422.91M |
Nordson Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NDSN, the sentiment is Neutral. The current price of 322.56 is below the 20-day moving average (MA) of 324.10, below the 50-day MA of 323.09, and above the 200-day MA of 296.73, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 48.54 is Neutral, neither overbought nor oversold. The STOCH value of 58.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NDSN.
Nordson Risk Analysis
Nordson disclosed 25 risk factors in its most recent earnings report. Nordson reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksNordson Peers Comparison
Overall Rating
IEX79Outperform
ITT78Outperform
DOV77Outperform
NDSN74Outperform
GGG71Outperform
FLS63Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | $17.16B | 32.45 | 13.31% | 1.24% | 6.93% | 14.08% | |
| 78Outperform | $18.51B | 42.44 | 9.10% | 0.73% | 35.82% | -19.39% | |
| 77Outperform | $27.42B | 23.83 | 15.43% | 1.01% | 8.24% | -47.25% | |
| 74Outperform | $17.97B | 32.48 | 17.59% | 1.05% | 7.02% | 24.24% | |
| 71Outperform | $11.46B | 22.65 | 19.92% | 1.65% | 5.39% | 5.94% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 63Neutral | $10.22B | 40.33 | 11.35% | 1.08% | 0.21% | -42.26% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NDSN | Nordson Corporation | 322.56 | 97.79 | 43.51% | |
| DOV | Dover Corporation | 206.12 | 28.30 | 15.92% | |
| FLS | Flowserve | 80.60 | 14.05 | 21.11% | |
| GGG | Graco Inc | 71.46 | -6.77 | -8.66% | |
| IEX | Idex Corporation | 233.57 | 74.08 | 46.45% | |
| ITT | ITT Corporation | 207.48 | 26.29 | 14.51% |
Nordson Corporate Events
Nordson acquires Contrinex to expand sensing portfolio
PositiveOn October 23, 2026, Nordson Corporation announced that its wholly owned subsidiary Nordson London Limited completed the acquisition of Contrinex Holding SA, a Swiss-based manufacturer of inductive, photoelectric and smart measurement sensors. Contri...
Nordson Delivers Record Q3 Results, Raises 2026 Guidance
PositiveOn August 19, 2026, Nordson reported record fiscal third-quarter results for the period ended July 31, 2026, posting all-time high sales of $818 million, up 10% year over year, and net income of $153 million, or $2.73 per diluted share. Adjusted earn...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026
